Nipro PharmaPackaging, a global provider of glass tubing, glass primary packaging, and medical devices, has launched its new D2F (Direct-to-Fill) glass vials, featuring Stevanato Group’s EZ-fill technology, to offer a high-quality ready-to-use (RTU) solution.
 
Key Features of D2F Glass Vials include

• D2F glass vials are washed, depyrogenated, packaged in nest & tub formats, and sterilized providing a RTU solution.
Pharmaceutical companies can integrate these vials directly into their aseptic fill-finish processes.
• Developed in collaboration with leading machine suppliers, D2F vials are compatible with a wide range of fill-finish lines for quick integration.
• D2F vials’ nest & tub design prevents glass-to-glass contact, reducing risks of breakage, cosmetic defects, and particle generation during transportation and handling. 

“We are excited to introduce D2F glass vials, offering a reliable and efficient RTU packaging solution that addresses the evolving needs of the pharmaceutical industry,” said Stephan Arnold, CEO Nipro PharmaPackaging. “These vials exemplify our mission to delivering trust with premium primary pharma packaging solutions.”


 
“The collaboration with Nipro represents another important milestone for Stevanato Group’s EZ-fill pre-sterilized platform,” said Mauro Stocchi, Chief Business Officer at Stevanato Group. “Nipro’s adoption of the EZ-fill platform further validates Stevanato Group’s technological leadership in secondary packaging for aseptic manufacturing. The EZ-fill platform is an increasingly reliable, scalable, and cost-effective solution and industry-validated technology, and we believe it will become a widely recognized standard in the industry.”